EUSA Pharma take on Novelion CEO Jeffrey Hackman to lead US expansion

The Hertfordshire-based speciality pharma firm EUSA Pharma has appointed Jeffrey S Hackman as President of the company’s United States operations.

Hackman will lead the Hemel Hampstead-based oncology and rare diseases specialist’s expansion into the US, as the company establishes new headquarters in Boston, Massachusetts.

To support the move, EUSA is rapidly expanding it sales, marketing, market access and medical teams, as it intends to launch a new oncology and rare diseases sales force, backed by a full medical and commercial team.

Lee Morley, EUSA Pharma's Chief Executive Officer, commented: “We are delighted to welcome Jeff to EUSA to lead our expansion in the United States and complete our strategic transatlantic commercial platform. EUSA is well established as a successful oncology and rare disease business in Europe, and we have the same ambition for our company in the United States. In the coming weeks, we plan to launch our significantly expanded commercial team, providing a platform to grow our in-house products and attract additional products from third parties.”

Pharma veteran Hackman brings more than 30 years of experience to his new role as he comes from his current position of interim CEO and Chief Operating Officer at Canadian firm Novelion Therapeutics.

Prior to his head position at Novelion, Hackman took on the role of Senior VP and Head of US Internal Medicine / Oncology at Shire Inc, following a period in which he led the company’s US oncology franchise.

Hackman himself commented: “I am thrilled to join EUSA at this exciting time for the company. Since its establishment in 2015, the company has made tremendous progress and I look forward to playing a key role in its rapid growth in the US. EUSA is gaining an enviable reputation in the oncology and rare disease markets, and I am excited at the prospect of building a successful US organization as part of the company's global ambitions.”

Mission Statement

Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,

Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches